| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10744854 | Parkinsonism & Related Disorders | 2015 | 9 Pages |
Abstract
This review highlights the need to identify whether the nature and extent of microglial activation in Lewy body dementia can be linked to structural change, progression of domain specific cognitive symptoms and peripheral inflammation as a marker of central microglial pathology. Answers to these questions will enable the evaluation of immunotherapies as potential therapeutic options for prevention or treatment of dementia with Lewy bodies and Parkinson's disease dementia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Ajenthan Surendranathan, James B. Rowe, John T. O'Brien,